Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 4,722Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Farmak, a,s

02 1Medichem S.A.

03 1AX Pharmaceutical Corp

04 2C-SQUARED PHARMA LIMITED

05 1CARBOGEN AMCIS AG

06 1Curia Wisconsin, Inc.

07 1DARMERICA, LLC

08 1FDC Limited

09 1Indoco Remedies Limited

10 2LAURUS LABS LIMITED

11 1Maithri Drugs Private Limited

12 1Micro Labs Limited

13 1Piramal Healthcare (Canada) Limited

14 1Piramal Pharma Limited

15 1Professional Compounding Centers of America

16 1Professional Compounding Centers of America dba PCCA

17 1Symed Labs Limited

18 1Unichem Laboratories Limited, India

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothFarmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

BRIMONIDINE TARTRATE

NDC Package Code : 63278-0488

Start Marketing Date : 2002-01-01

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

Farmak Company Banner

02

arrow
BioAsia
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMedichem is a vertically integrated pharmaceutical company specializing in the development & manufacturing of APIs & FDFs.

BRIMONIDINE TARTRATE

NDC Package Code : 53296-0050

Start Marketing Date : 2014-09-01

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (75kg/75kg)

Marketing Category : BULK INGREDIENT

Medichem

04

BioAsia
Not Confirmed
arrow

05

BioAsia
Not Confirmed
arrow

06

BioAsia
Not Confirmed
arrow

07

BioAsia
Not Confirmed
arrow
arrow
BioAsia
Not Confirmed

BRIMONIDINE TARTRATE

NDC Package Code : 42571-354

Start Marketing Date : 2021-02-19

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (10kg/10kg)

Marketing Category : BULK INGREDIENT

blank

08

BioAsia
Not Confirmed
arrow
arrow
BioAsia
Not Confirmed

BRIMONIDINE TARTRATE

NDC Package Code : 51927-0063

Start Marketing Date : 2021-04-08

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (10kg/10kg)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

blank

09

BioAsia
Not Confirmed
arrow
arrow
BioAsia
Not Confirmed

BRIMONIDINE TARTRATE

NDC Package Code : 51927-4992

Start Marketing Date : 2017-08-17

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

blank

10

BioAsia
Not Confirmed
arrow

Looking for 109826-56-4 / Brimonidine Tartrate API manufacturers, exporters & distributors?

Brimonidine Tartrate manufacturers, exporters & distributors 1

19

PharmaCompass offers a list of Brimonidine Tartrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Brimonidine Tartrate manufacturer or Brimonidine Tartrate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Brimonidine Tartrate manufacturer or Brimonidine Tartrate supplier.

PharmaCompass also assists you with knowing the Brimonidine Tartrate API Price utilized in the formulation of products. Brimonidine Tartrate API Price is not always fixed or binding as the Brimonidine Tartrate Price is obtained through a variety of data sources. The Brimonidine Tartrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Brimonidine Tartrate

Synonyms

70359-46-5, Alphagan, Brimonidine tartarate, Brimonidine l-tartrate, Lumify, Brimonidinne tartrate

Cas Number

109826-56-4

Unique Ingredient Identifier (UNII)

4S9CL2DY2H

About Brimonidine Tartrate

A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.

Brimonidine Tartrate Manufacturers

A Brimonidine Tartrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Brimonidine Tartrate, including repackagers and relabelers. The FDA regulates Brimonidine Tartrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Brimonidine Tartrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Brimonidine Tartrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Brimonidine Tartrate Suppliers

A Brimonidine Tartrate supplier is an individual or a company that provides Brimonidine Tartrate active pharmaceutical ingredient (API) or Brimonidine Tartrate finished formulations upon request. The Brimonidine Tartrate suppliers may include Brimonidine Tartrate API manufacturers, exporters, distributors and traders.

click here to find a list of Brimonidine Tartrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Brimonidine Tartrate NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Brimonidine Tartrate as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Brimonidine Tartrate API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Brimonidine Tartrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Brimonidine Tartrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Brimonidine Tartrate NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Brimonidine Tartrate suppliers with NDC on PharmaCompass.

Brimonidine Tartrate Manufacturers | Traders | Suppliers

Brimonidine Tartrate Manufacturers, Traders, Suppliers 1
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.